West Pharmaceutical Services | WST - Net Income


West Pharmaceutical Services reported $154M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Align Technology USD 108.29M 4.48M Jun/2026
Baxter International USD 126M 141M Jun/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Cerus USD -20.92M 17.98M Dec/2024
Charles River Laboratories USD -1.48M 13.36M Jun/2026
Cooper Companies USD -77.9M 208.7M Mar/2026
Dentsply International USD -10M 136M Mar/2026
Haemonetics USD 33.01M 53.16M Jun/2026
ICU Medical USD 30.13M 45.87M Mar/2026
Insulet USD 95M 3.9M Jun/2026
Integra LifeSciences USD 4.48M 9.1M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
J&J USD 5.53B 299M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Neogen USD -11.3M 5.7M Mar/2026
OraSure Technologies USD -19.29M 5.57M Dec/2025
Quidel USD -91.8M 38.9M Mar/2026
Repligen USD 5.01M 3.32M Jun/2026
Rockwell Medical USD 343K 2.07M Jun/2024
Solventum Corp USD 92M 79M Jun/2026
STAAR Surgical USD 5.21M 23.52M Mar/2026
Terumo JPY 26.37B 6.28B Mar/2026
Utah Medical Products USD 2.6M 38K Mar/2026
West Pharmaceutical Services USD 154M 15.2M Jun/2026